Plain-Language Research Brief: Sunscreen and Melanoma Study Challenges
For decades, epidemiological research investigating whether sunscreen prevents cutaneous melanoma produced seemingly contradictory results. Some observational projects suggested lower risks, while others paradoxically showed higher rates of skin cancer among regular sunscreen users. A meta-analysis published in the International Journal of Cancer examined these conflicting signals by analyzing how study structures, confounding variables, and exposure biases alter reported outcomes.
Study Design and Structure of the Evidence Base
The 2019 review, titled Challenges in assessing the sunscreen-melanoma association, conducted a systematic review of human studies published up to February 28, 2018. Across publication dates spanning from 1979 to 2018, the investigators evaluated a total of 21,069 melanoma cases across 28 studies.
Rather than evaluating all data as a single uniform pool, the authors stratified their analysis by study design to account for systematic differences in how information was gathered. The 28 studies comprised:
- 23 case-control studies, which included 11 hospital-based studies and 12 population-based studies
- 1 ecological study
- 3 cohort studies
- 1 randomised controlled trial
This stratification was essential because observational designs track behaviors in uncontrolled real-world environments, whereas a randomised controlled trial assigns usage under strict experimental protocols.
Contrasting Findings Across Different Methodologies
The meta-analysis revealed marked heterogeneity across different research designs when comparing ever-use of sunscreen against never-use. In the single randomised controlled trial included in the paper, sunscreen use demonstrated a protective effect, recording a hazard ratio of 0.49. Similarly, lower risks were identified in the ecological study, which reported a rate ratio of 0.48, and across hospital-based case-control studies, which showed an adjusted odds ratio of 0.57.
In contrast, observational settings that relied on broader community self-reporting yielded entirely different results:
- Population-based case-control studies showed no clear protective association, yielding an odds ratio of 1.17.
- Cohort studies identified a positive association, yielding a hazard ratio of 1.27, which superficially suggested higher melanoma rates among sunscreen users.
These stark discrepancies between randomized testing and observational surveys underline why raw observational numbers cannot be taken at face value without exploring underlying biases.
Understanding Confounding by Indication
The paper concluded that observational evidence regarding sunscreen and melanoma was weak and heterogeneous, largely due to the difficulty of adjusting for innate confounding by indication. In real-world settings, sunscreen use does not occur at random. Individuals with sun-sensitive skin phenotypes, such as fair skin, a tendency to burn easily, or multiple moles, are far more likely to buy and apply sunscreen. These same physical traits are established baseline risk factors for melanoma.
Furthermore, people who plan to spend extended periods under intense sunlight frequently apply sunscreen specifically to prolong their outdoor exposure. When researchers adjusted their statistical models for confounding factors like total sun exposure, sunburn history, and physical phenotype, the association systematically shifted toward decreased melanoma risk among sunscreen users. This shift indicates that the apparent elevated risk in simple observational comparisons was an artifact of high-risk individuals using the product most often.
Factors Influencing Study Heterogeneity
Using stratified meta-analysis and meta-regression, the study authors mapped out specific variables that altered the relationship between sunscreen use and melanoma across the literature. Significant sources of variation included:
- Geographic Region: Differences between global research locations showed significant interaction (p = 0.008).
- Latitude: Variations in solar intensity based on latitude contributed meaningfully to the diverging data (p = 0.042).
- Adjustment for Moles and Freckles: Whether a study controlled for naevi and freckling significantly shifted the resulting risk estimates (p = 0.035).
- Baseline Usage Patterns: The overall proportion of never-sunscreen users within the study population also modified the observed associations.
Understanding these variables helps contextualize why general sun safety advice must look beyond isolated observational reports. Proper photoprotection concepts are explored further in our guide to Sunscreen Basics: SPF, Broad Spectrum and Water Resistance Explained.
Clinical Takeaways and Research Limitations
The primary limitation identified by the authors is the heavy reliance on observational literature where confounding by indication cannot be fully removed. Because only one randomised controlled trial existed in the dataset, evaluating lifelong prevention through high-certainty experimental setups remains rare. Nevertheless, that single trial demonstrated a protective effect, and statistical adjustments across observational studies consistently pointed toward risk reduction once exposure and susceptibility factors were addressed.
For individuals managing sun sensitivity or monitoring personal skin changes, working directly with a qualified doctor or dermatologist is essential. Self-directed tanning trends or unapproved compounds, such as synthetic melanotan peptides sold on the black market, lack clinical oversight and carry significant unknown hazards. Discussing personal UV risks and mole patterns with a medical professional remains the standard for evidence-based care, as outlined in our overview of Melanotan, Moles and Melanoma: What Case Reports Show.
Sources
Challenges in assessing the sunscreen-melanoma association. (International Journal of Cancer, 2019)
Published October 28, 2026. Sources are linked in the text. See our Medical Disclaimer.